Literature DB >> 8203963

Antiperinuclear and anti-RA33 antibodies in juvenile chronic arthritis.

G Nesher, V K Wilson, T L Moore, T G Osborn, V E Hanna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8203963      PMCID： PMC1005313          DOI： 10.1136/ard.53.4.282-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  Antiperinuclear factor in juvenile rheumatoid arthritis.

Authors:  G Nesher; T L Moore; M W Grisanti; E el-Najdawi; T G Osborn
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis.

Authors:  C Gabay; A M Prieur; O Meyer
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103
  2 in total
  3 in total

1.  Antiperinuclear factor in the polyarticular form of juvenile chronic arthritis: are use of frozen material or age of patients relevant?

Authors:  J M Berthelot
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

2.  Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Authors:  T Avcin; R Cimaz; F Falcini; F Zulian; G Martini; G Simonini; V Porenta-Besic; G Cecchini; M O Borghi; P L Meroni
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

3.  Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.

Authors:  Anne E Tebo; Troy Jaskowski; K Wayne Davis; April Whiting; Bronte Clifford; Andrew Zeft; Bernadette McNally; Harry R Hill; John Bohnsack; Sampath Prahalad
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-29       Impact factor: 3.054
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.